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The apparent active site of human leukocyte gly- 
coasparaginase (N4-(~-acetylglucosaminy~)-~-aspa- 
raginase EC 3.5.1.26) has been studied by labeling 
with an  asparagine analogue, 5-diazo-4-oxo-~-norva- 
line. Glycoasparaginase was  purified 4,600-fold from 
human leukocytes with an overall recovery of 12%. 
The purified enzyme has a K,,, of 110 p ~ ,  a Vma, of 34 
pmol X 1” X min”, and a specific activity of 2.2 units/ 
mg protein with N4-(~-N-acetylglucosaminyl)-~-as- 
paragine as substrate.  The  carbohydrate  content of the 
enzyme is 15%, and it exhibits  a broad pH  maximum 
between 7 and 9. The  88-kDa  native enzyme is com- 
posed of 19-kDa  light  (L)  chains  and  25-kDa  heavy (H) 
chains  and it has a heterotetrameric  structure of L2Hz- 
type. The glycoasparaginase activity  decreases  rapidly 
and  irreversibly in the presence of 5-diazo-4-oxo-~- 
norvaline. At any one concentration of the compound, 
the inactivation of the enzyme is pseudo-first-order 
with time. The  inhibitory  constant, Kr, is 80 PM and 
the second-order rate constant  1.25 X lo3 M-’ min“ at 
pH 7.5. The enzyme activity  is competitively protected 
against  this  inactivation by its  natural  substrate, as- 
partylglucosamine, indicating that  this  inhibitor binds 
to the active site or very close to it. The covalent 
incorporation of [5-’4C]dia~~-4-~~~-~-norvaline par- 
alleled the loss of the enzymatic activity  and one inhib- 
itor binding site was localized to each L-subunit of the 
heterotetrameric enzyme. Four peptides with  the ra- 
dioactive label were  generated,  purified by high per- 
formance liquid chromatography, and sequenced by 
Edman degradation.  The sequences were  overlapping 
and  all contained the  amino-terminal  tripeptide of the 
L-chain. By mass spectrometry,  the  reacting  group of 
6-diazo-4-oxo-L-norvaline was characterized as 4- 
oxo-L-norvaline that  was bound through an  wketone 
ether linkage to the hydroxyl group of the amino- 
terminal amino acid threonine. 
The lysosomes of mammalian cells contain  a glycoaspara- 
ginase (N4-(@-acetylglucosaminyl)-~-asparaginase, aspartyl- 
glycosylaminase, aspartylglucosaminidase, glycosylasparagi- 
nase, EC 3.5.1.26) that  is involved in  the degradation of the 
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N-glycosidic linkage between asparagine and N-acetylglucos- 
amine in various asparaginylglycopeptides. The substrate N4- 
(P-N-acetylglucosaminy1)-L-asparagine (aspartylglucosa- 
mine) is hydrolyzed by the enzymes to  aspartate  and  l-amino- 
N-acetylglucosamine. The latter product is further cleaved 
nonenzymatically to ammonia and N-acetylglucosamine (1). 
Human liver has been reported to contain  a monomeric as- 
partylglucosaminidase of 80 kDa (2)  and  a trimeric enzyme 
of  60 kDa consisting of three nonidentical polypeptides (3), 
both with a pH maximum at 6.1, in addition to  an undetailed 
aspartylglucosaminidase with a pH maximum at 7.5 (4). The 
rat liver aspartylglucosaminidase is a heterodimeric protein 
of 43 kDa that contains two noncovalently bound subunits 
and has a broad maximum between pH 6.5 and 10 (5). The 
amino-terminal sequences of its subunits have been deter- 
mined ( 5 ) .  Lack of the glycoasparaginase activity in humans 
results in a lysosomal storage disease called aspartylglycosa- 
minuria (McKusick 20840) characterized with severe psycho- 
motor retardation and accumulation of glycoasparagines in 
tissues and body fluids (1). 
Bacterial (6) and yeast (7) asparaginases can hydrolyze D- 
or L-asparagine with free cy-amino and a-carboxyl groups to 
yield aspartate  and ammonium ion. In addition to asparagine, 
bacterial glutaminase-asparaginases are able to hydrolyze glu- 
tamine  to yield glutamic acid and ammonium ion (8). Inhibi- 
tors of these related amidohydrolases have proved useful in 
understanding the characteristics of the enzymes. An bas-  
paragine analogue 5-diazo-4-oxo-L-no~aline (DONV)’ has 
been used to label the active site of Escherichia coli L-aspa- 
raginase (9). Glutaminase-asparaginases are similarly inhib- 
ited  and labeled by the next larger homologue of DONV, 6- 
diazo-4-oxo-~-norleucine (DON), which binds to threonine 
hydroxyls in  an 8-residue segment identical in both Acineto- 
bacter and Pseudomonas 7A glutaminase-asparaginase en- 
zymes (10). DONV has been shown to irreversibly inhibit hen 
oviduct (11) and rat liver glycoasparaginase (12), but no 
further  characterization of the adduct was  done. The effect of 
the amidohydrolase inhibitors on human glycoasparaginases 
has  not been studied. In  this paper, we describe purification 
of heterotetrameric glycoasparaginase from human leukocytes 
and  report our findings that 5-diazo-4-oxo-~-no~aline is an 
irreversible inhibitor of the enzyme. We also show that  the 
compound is an active site-directed inhibitor or affinity label 
The abbreviations used are: DONV, 5-diazo-4-oxo-~-norvaline; 
HPLC, high performance liquid chromatography; ONV, 4-0XO-L- 
norvaline; DON, 6-diazo-4-oxo-~-norleucine; PTC, phenylthiocarba- 
myl; TEA, triethylamine;  PITC, phenylisothiocyanate; DTT, dithio- 
threitol; PMSF, phenylmethylsulfonyl fluoride; PAGE, polyacryl- 
amide gel electrophoresis; SDS, sodium dodecyl sulfate. 
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FIG. 1. Loss of glycoasparaginase activity during incuba- 
tion with DONV. Enzyme (4.8 pg, 9.6 milliunits) was incubated 
with DONV in 50 mM phosphate buffer, pH 7.5, at 25 "C. At the time 
indicated, an aliquot of each solution was assayed for enzyme activity 
(11) at 37 "C for 15 min. 0, no inhibitor; 0, 5 p M  DONV; 0, 10 p M  
DONV; ., 20 pM DONV; A, 40 pM DONV; A, 60 pM DONV; +, 200 
p~ DONV. Inset, effect of DONV concentration on the pseudo-first- 
order constant kabs at pH 7.5, 25 "C. Rate constant ( k 3 )  and steady- 
state constant (&) were calculated form the slope (16). 
and  that a  threonine hydroxyl is alkylated to form an  ether 
linkage with the reacting group of the inhibitor. 
MATERIALS AND METHODS* 
RESULTS 
5-Diazo-4-oxo-~-norvaline at each concentration caused 
progressive, irreversible inhibition of glycoasparaginase activ- 
ity in a pseudo-first-order reaction under conditions that 
maintained the activity of the enzyme in  the absence of the 
reagent (Fig. 1). The activity of the enzyme could not be 
restored by extensive dilution or dialysis of the inhibited 
enzyme. The hyperbolic relationship between the pseudo- 
first-order constant and concentration of DONV (data not 
shown) indicates that  the inhibitor forms a reversible, preal- 
kylation complex with the enzyme (16, 17).  Thus,  the inhibi- 
tion corresponds to  the mechanism 
k ,  K3 
k,  
E + I +  E.I+ E - X ,  K I =  kzlkl 
where E - X is the irreversibly inactivated enzyme and follows 
the form 
kobs = k3[1]/(K1 + [ I ] )  
The second-order rate  constant corresponding to [ I ]  << Kr is 
given by  k3/K1. 
A plot of l/kob, against l/(DONV) showed a linear relation- 
ship typical of hyperbolic saturation (Fig. 1, inset). The 
steady-state constant (&) and  the  rate  constant ( k 3 )  in 50 
mM phosphate buffer, pH 7.5, calculated from the slope  were 
K, = 80 p ~ ,  k3 =0.10  min" and  the second-order rate  constant 
= 1.25 X lo3 "' min". In order to determine if  DONV reacts 
with some group at  the active site of the enzyme, we studied 
the effect of the substrate, aspartylglucosamine, on the inac- 
tivation rate. The presence of substrate in the same medium 
with the inactivator competitively inhibited the inactivation 
of glycoasparaginase with an inhibition  constant KL = 98 p~ 
(Fig. 2). 
To determine the region of glycoasparaginase modified by 
Portions of this paper (including "Materials and Methods," part 
of "Results," Figs. 6-11, and Tables IV-VI) are  presented in miniprint 
a t  the  end of this paper.  Miniprint is easily read with the aid of a 
standard magnifying glass. Full size photocopies are included in the 
microfilm edition of the  Journal  that is available from Waverly Press. 
~ ~ ~~~~ 
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FIG. 2. Effect of substrate  and  inhibitor  concentrations on 
the  pseudo-first-order rate constant kob at 7.5, 25 "C. Gly- 
coasparaginase (5 pg, 10 milliunits) was incubated without substrate 
(.) and in the presence of 50 pM (O), 100 pM (A), and 200 pM (A) 
aspartylglucosamine and 5-300 p~ inhibitor ( I )  DONV in 50 mM 
phosphate buffer. Inset, a graph of the slopes against substrate 
concentration. An inhibition constant (KL) for substrate to protect 
against inactivation by  DONV was calculated from the intercept on 
the S axis (-KL) (derived from Refs. 16, 17). 
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FIG. 3. HPLC separation of L- and H-chains from 1 nmol of 
[5-14C]DONV-labeled glycoasparaginase. Vydac C-4 column (2.1 
mm X 25 cm) was eluted at a flow rate of 0.2 ml/min. Eluent A was 
0.1% trifluoroacetic acid in water and B was 0.1% trifluoroacetic acid 
in acetonitrile. Gradient: 20% B (15 min); 20-80% B (15-75 min). 
The detection wavelength was  225 E , I L  The lower panel presents the 
radioactivity from 5% of each fraction. 
DONV, the enzyme was radioactively labeled in the presence 
of [5-'4C]DONV for 24 h. The completely inhibited enzyme 
was further incubated for another 2 h in the presence of 1,000- 
fold excess of unlabeled DONV and injected onto the reverse- 
phase  HPLC column. Monitoring of the eluent by the absorb- 
ance at 225 nm  and radioactivity showed that only the light 
chain of the enzyme eluting at 34% of solvent B was  effectively 
radiolabeled (Fig. 3). Background levels of radioactivity were 
found with the heavy subunit  eluting at 43% of solvent B and 
any of the other components in the chromatograms. Taking 
into consideration that  the glycoasparaginase-DONV adduct 
lost about 20% of its label during repeated chromatographic 
runs in 0.1% trifluoroacetic acid, 1.3 mol of [5-'4C]DONV  was 
bound/mol of enzyme or 0.7 mol/mol of L-subunit. 
After total proteolysis of the [5-'4C]DONV-labeled L-chain 
with chymotrypsin, the peptides were separated by reverse- 
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FIG. 4. A ,  HPLC separation of chymotryptic peptides from 
1 nmol of [S-"C]DONV-labeled L-chain. Vydac C-18 column 
(2.1 mm X 25 cm) was eluted at a flow rate of  0.2 ml/min. Eluent A 
was  0.1% trifluoroacetic acid in water and B was  0.1% trifluoroacetic 
acid in acetonitrile. Gradient: 2% B (10 min); 2-25% B (10-85 min). 
The lower panel  presents the radioactivity from 5% of each fraction. 
Arrows indicate the radioactive peptides a t  the elution times of 62 
min (CH1) and 80 min. B,  rechromatography of the radioactive 
peptides ( A )  obtained at 80 min of elution time. The chromatography 
was carried out as described in the legend of A with the exception 
that gradient was 1530% B (120 rnin). The lower panel  presents the 
radioactivity from 20% of each fraction. The arrow indicates the 
radioactive peptide CH2. C, HPLC separation of CNBr-peptides from 
1 nmol of [5-I4C]DONV-labeled L-chain. Column and eluents were 
as described in A. Gradient: 2% B (10 rnin); 2-30% B (10-70 rnin); 
30-6075 B (70-125 min); 60-80% B (125-155 min). The lower panel 
presents the radioactivity from 20% of each fraction. The arrows 
indicate the radioactive peptides CB1 and CB2 at  the elution times 
of 13 and 27 min. 
phase HPLC. Most of the radioactivity was  localized in two 
peptide peaks eluting at 18% (CH1) and at 23% of solvent B, 
respectively (arrows in Fig. 4A). Since the shape of the  latter 
peak was indicative of a peptide mixture, these  fractions were 
combined and applied to  the same column in  15% solvent B. 
Rechromatography with a '  shallower gradient resulted in a 
single peak (CH2) eluting at 21% of solvent B (Fig. 4B). In  a 
parallel experiment the modified protein was subjected to 
chemical cleavage in the presence of cyanogen bromide. The 
DONV-labeled L-chain was stable in 70% formic acid and 
after cyanogen bromide cleavage,  two major peaks of radio- 
activity coeluted with two small peptide peaks CB1 and CB2 
at 3 and 10% of solvent B, respectively (Fig. 4C). 
The purified, radioactive peptides were lyophilized and 
subjected to sequence analysis by Edman degradation. The 
absence of significant secondary amino acid or unknown 
peaks indicated high purity of the peptides. The chymotryptic 
peptide CHI was a tripeptide of Thr-Ile-Gly. The peptide 
CH2 consisted of seven amino acids with the same Thr-Ile- 
Gly sequence at its  amino-terminal  end  (Table I). The radio- 
active cyanogen bromide fragments CB1 and CB2 showed 
identical tripeptide sequences of Thr-Ile-Gly in Edman deg- 
radation  (Table I). All the sequences obtained from the pep- 
tides were identical to  the amino-terminal  end of the  intact 
L-subunit (Table I). Further localization of the inhibitor- 
binding site by this method was unsuccessful, since the radio- 
activity could not be  localized to  any particular cleavage  cycle 
presumedly because it was either flushed away by 100% triflu- 
oroacetic acid before the actual sequencing cycles or found to 
be retained on the sample filters  after the sequencing proce- 
dure. The combined evidence demonstrates that  the reacting 
site of 5-diazo-oxo-norvaline to human leukocyte glycoaspa- 
raginase is within a few amino-terminal amino acids of its L- 
subunit. 
To identify the residues involved in the covalent modifica- 
tion of the glycoasparaginase by 5-diazo-oxo-norvaline, the 
enzyme was labeled with nonradioactive DONV. The L-sub- 
unit was purified under conditions identical to those used for 
[5-14C]DONV labeling, digested with trypsin,  and the peptides 
were isolated by HPLC as described earlier. The mass spec- 
trum of the HPLC fraction collected at 30% of solvent B 
(data  not shown) consisted of two strong (M+H)' signals at 
m/z 997 and 1,125. The ion at m/z 997 matches the value 
expected for the N-terminal  tryptic peptide from the 0-sub- 
unit.  Formation of the DONV-peptide adduct by nucleophilic 
substitution would increase the mass of this peptide by 128 
daltons to m/z 1,125. Analysis of the ion at m/z 1,125 by 
collision-activated dissociation (22-24) produced the mass 
spectrum in Fig. 5. The predicted fragment ions, type  b  and 
y" (22), are displayed with the structure in the figure, and 
those ions observed in the mass spectrum are underlined. To 
provide additional  support for the localization of the label to 
TABLE I 
The sequences of [5-'4C]DONV-lubekdpeptides CHI, CH2, CBI and 
GB2 as well as the N-terminal sequences of L- and H-subunits of 
human leukocyte glycoasparaginase 
1 nmol of each subunit was used for sequencing and picomoles  of 
phenylthiohydantoin-amino acids analyzed are shown in  parenthesis. 
X, no  amino acid signal above the background was detected. 
Cycle 
Amino acid Amino acid 
CH1 CH2 CB1 CB2 Light chain Heavy chain 
P m l  
1 Thr  Thr  Thr Thr Thr (380) Ser (109) 
2 Ile Ile Ile Ile Ile (430) X 
3 Gly  ly  Gly  ly  Gly (303) Pro (250) 
4 Met  Met (1430)  Leu (405) 
5 Val  Val (950) Pro (405) 
6 Val  Val  (1080) Leu (500) 
7 Ile Ile (350) Val  (313) 
8 His (65) Val (412) 
9 Lys (568)  Asn (92) 
10 Thr (240) Thr (31) 
11 Gly  (160) Try (47) 
12 His (44) Pro (153) 
13 Ile (170) Phe (152) 
14 Ala  (230)  Lys (131) 
15 Ala (260) 
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FIG. 5. Collision-activated disso- 
ciation mass spectrum of the ion at 
m/z 1,125 of the peptide ONV-Thr- 
Ile-Gly-Met-Val-Val-Ile-His-Lys, 
residues 1-9 of DONV-labeled L- 
chain of human leukocyte glycoas- 
paraginase. The collision energy was 
27 eV, and the argon pressure in the 
collision cell was 3 x Torr. The 
structure is labeled with fragment ions 
of type b, above, and type y", below. 
Those fragment ions observed in the 
mass spectrum  are underlined. 
1 1x50 
100 
ea 
60 
40 
20 
'1 
Y"2 
Y"4 
Y"3 
I 
bl 
260 
TABLE I1 
Fragment ions and ion  intensities observed in the collision actiuated 
dissociation mass spectra of 4-oxo-~-norvaline-Thr-Ile-Gly-Met-Val- 
Val-His-Ile-Lys  and 4-oxo-~-norvaline-Thr-Ile-Gly-Met-Val-Val- 
His-Ile-Lys  methyl  ester 
Sequence m f f  Intensityb m/z' Intensityb 
ions 
Y "I 147 161 0.64 
Y *'z 284 1.43 298 5.77 
Y "3 397 1.15 411 2.42 
Y"4 496 1.48 510 2.37 
Y !>5 595 0.56 609 1.46 
YN6 726 0.28 740 0.81 
Yl'? 783 0.95 797 1.61 
Y"8 896 0.29 910 
(M+H)' 1,125 
0.45 
100.0 1,153 100.0 
Free acid collision-activated dissociation mass spectrum. 
Relative intensities. 
' Methyl ester collision-activated dissociation mass spectrum. 
the threonine residue, this peptide was converted to  its cor- 
responding methyl ester derivative. Formation of the methyl 
ester would shift the  (M+H)+ of the labeled peptide by 28 
daltons to m/z 1,153, since the addition of the DONV label 
would place a free acid at  the N terminus of the peptide. 
Additionally, the m/z values for the y" ions series in the 
collision-activated dissociation mass spectrum would increase 
by 14 daltons (reflecting the addition of a methyl ester at  the 
C terminus) except for the y" ions associated with fragmen- 
tation of the amide bond on the N-terminal side of the 
modified amino acid. These y" ions will increase by an addi- 
tional 14 daltons since the a-carboxylic acid of the DONV 
label also formed the methyl ester. This shift in mass is 
observed between y"8 (cleavage of the amide bond between 
Thr and Ile) and  the  (M+H)+ ion (Table 11), clearly showing 
the label is located on the threonine residue. 
DISCUSSION 
In  this work, glycoasparaginase was purified 4,600-fold from 
human leukocytes. Throughout the purification of the en- 
460 660 
(&ti)* - ONV 1 2.23 
- 
d o 0  
zyme, we monitored its activity with its natural substrate 
using a new, specific assay for glycoasparaginase activity (15). 
The purified enzyme was obtained with a  12% overall yield. 
Gel electrophoresis under reducing conditions revealed that 
the enzyme protein  runs  as two separate bands nominated as 
light (L) and heavy (H) subunits with apparent M, of 19,000 
and 25,000, respectively. Since the amounts of L- and H- 
subunits according to SDS-PAGE  and reverse-phase HPLC 
are very similar, and on native PAGE the enzyme runs  as  a 
single band at 83,000, a quaternary structure of LzH2-type 
with an apparent M, of 88,000 for the native glycoasparagi- 
nase is suggested. The  pH optimum of glycoasparaginase of 
human leukocytes and chorionic villous cells is 7-9 (15), which 
is extraordinarily high for lysosomal enzymes that usually 
have an acidic optimum. At pH 4-5, the leukocyte glycoas- 
paraginase had only 0-10% of its activity at 7.5,  which  may 
reflect unknown catabolic characteristics of the enzyme dif-  
ferent from most lysosomal exoglycosidases. The enzymatic 
activity of the dissociation intermediates of human leukocyte 
glycoasparaginase suggests that  its action requires association 
of at least one of each chain, which  by themselves are enzy- 
matically inactive. A recent  report indicates the presence of a 
heterodimeric glycoasparaginase of M, 43,000 with a broad 
pH maximum between 6.5 and 10 in  rat liver (5). The amino- 
terminal sequences of the  rat enzyme have high similarity to 
those of the human leukocyte enzyme. 
Since the free a-amino  and  a-carboxyl groups of asparagine 
were essential for the hydrolysis of the substrate, we synthe- 
sized an asparagine analogue 5-diazo-oxo-~-norvaline and 
studied its action on human leukocyte glycoasparaginase. 
Incubation of the compound with glycoasparaginase resulted 
in irreversible loss of its enzymatic activity. The specificity of 
the interaction between the asparagine analogue and the 
enzyme is demonstrated  in several ways: the glycoasparagi- 
nase activity is inhibited by DONV under conditions that 
maintain the activity of the enzyme without inhibitor, the 
inhibition follows pseudo-first-order kinetics at any one con- 
centration of the inhibitor, the enzyme activity is partially 
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TABLE I11 
Comparison of the  N-terminal  sequence of human leukocyte  glycoasparaginase L-chain (I), rat  liver 
glycosylasparaginase  light  chain (II) (5), Acinetobacter  glutaminase-asparaginase (III) (10, 28), Pseudomonas 7 A 
glutaminase-asparaginase (IV) (lo), and E. coli L-asparaginase (V) (30) 
A known reaction site for DONV (1) and DON (111. IV) are indicated in boldface. 
Peptide  Sequence 
I 
I1 
I11 
IV 
20 I 
V 
protected by its natural substrate, and a single amino acid 
residue is covalently  labeled by the  inhibitor. 
The  stoichiometry of [5-'4C]DONV binding  to glycoaspa- 
raginase was 0.7 mol of DONV/mol of L-subunit  indicating 
the existence of two inhibitor-binding  sites/one enzyme  mol- 
ecule or one each  L-chain.  The labeling efficiency is in ac- 
cordance with the sequencing finding  that  some of the  inhib- 
itor-binding sequence  was found  to be without  the label. The 
inhibitor-binding  site  to glycoasparaginase  could be localized 
within  the  three  most  amino-terminal  amino acid  residues of 
the  L-chain by automated  Edman  degradation  sequencing of 
[5-"C]DONV-labeled chymotryptic and cyanogen bromide 
peptides. The cyanogen  bromide cleavage produced two  pep- 
tides, CB1 and CB2, that had different retention times in 
reverse-phase  HPLC,  but  generated  identical sequences  upon 
Edman degradation. The  small  amounts of the  peptides  lim- 
ited mass spectrometric analysis, and no structure-related 
mass spectra could be recorded for them. The structural 
difference  between CB1  and CB2 is  most likely ascribed to a 
mixture of DONV-containing  tetrapeptides  with  homoserine 
and homoserine lactone at their  carboxyl-terminal  end.  Cyan- 
ogen bromide cleavage is known to produce both compounds, 
and it has been demonstrated that even octapeptides with 
identical sequences are separated from one another by re- 
verse-phase HPLC due  to  the  presence of either  homoserine 
or homoserine lactone at the carboxyl terminus (25). The 
final identification of the  amino acid  modified by the  inhibitor 
was accomplished by mass  spectrometry of tryptic  peptides. 
The reacting group of DONV was shown to be 4-0xo-L- 
norvaline bound through an a-ketone ether linkage to the 
hydroxyl  group of the  amino-terminal  amino acid, threonine. 
More generally, our  data show the applicability of mass spec- 
trometry  in  characterization  and localization of modifications 
in proteins.  Active-site-directed  irreversible inhibitors of en- 
zymes produce labile adducts often difficult to characterize 
by  chemical means (9, 10) and especially in  such cases, mass 
spectrometry  should be considered as  the  method of choice. 
The binding of the substrate analogues to the hydroxyl 
group of threonine or serine residues is a common feature 
between glycoasparaginase and  other amidohydrolases. The 
diazo  compounds,  like the  actual  substrates of the enzymes 
(26), are obviously attached  to  the  active  center of amidohy- 
drolases through  their  a-amino-  and  a-carboxyl groups. This 
is followed by a nucleophilic attack  in which the diazo nitro- 
gens  are cleaved off and  the positively charged  carbonium ion 
reacts with the negatively charged oxygen and a covalent 
oxygen-carbon bond  is  formed (10). Increased acidity of the 
hydroxyl group is suggested by this reaction in absence of 
catalyst. The acidity of amines is not  great enough to  react 
with the diazo group without a catalyst (27). Since both 
glycoasparaginase and  asparaginases recognize the  asparagine 
moiety with free w-amino and a-carboxyl groups and are 
inhibited  with  the  same  substrate analogue, it  is reasonable 
to  assume  that  this general reaction scheme applies to gly- 
coasparaginase  as well. 
The  amino-terminal sequence of the  human leukocyte gly- 
coasparaginase L-subunit shows considerable homology to 
that of bacterial amidohydrolases, and  it is highly similar  to 
the  light  subunit of the  rat liver  glycosylasparaginase (Table 
111). The  primary  structure of the  L-subunit of the  human 
glycoasparaginase has two significant differences compared 
to  the  other sequences: it  is  the only  enzyme to  contain  an 
amino-terminal  threonine  as well as  to lack threonine at the 
position  13  that  corresponds  to  the  DON-binding  threonine 
at  position  12  in Acinetobacter glutaminase-asparaginase (10, 
28) located within the conserved 8-residue fragment found 
also in Pseudomonas 7 A  glutaminase-asparaginase (lo), Er- 
winia chrysanthemi asparaginase (29), and E. coli asparagi- 
nase (30). The presence of the  amino-terminal  threonine  in 
human leukocyte glycoasparaginase is apparently of func- 
tional importance, since this particular residue forms the 
covalent  adduct  with [5-14C]DONV and  is replaced  in the  rat 
liver  enzyme by glutamine  (5). DONV is known to  inhibit  rat 
liver  glycoasparaginase, but  whether  it  is  bound  to  the  threo- 
nine at position 13  or elsewhere remains  to be shown. 
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SUPPLEMENTAL  MATERIAL 
T O  
GLYCOASPARAGINASE  FROM  HUMAN  LEUKOCYTES:  INACTIVATION  AND 
COVALENT MODIFICATION WITH DIAZO.OXONORVALINE 
BY 
VESA KAARTINEN.  JULIAN C. WILLIAMS, JOHN TOMICH, JOHN R. YATES 111, 
LEROY E. HOOD, AND ILKKA MONONEN 
Materials and  Methods 
the  Finnish  Red  Cross  Transfusion  Service,  Kuopio.  Finland.  The  donors were healthy 
Leukocytes were isolated  from  the  buffy coat of  human  blood  obtained  from 
Pmnish volunteers and  every  blood  sample was tested  beforehand  and  proved negauue 
in regard to cardiolipin.  HBsAC and antiLHIV. The  glycoside  rivatives of 4 -  
methylumbell~ferone.  N 4 - ( ~ - N - a c e t y l g l u c o a a m i n y I ) - L - ~ s p a r a g l n e ,  glutamic-aralacct lc-  
lransaminase  and  malic  dehydrogenase were from Sigma  Chemical  Company, St. Louis. 
MO.  U.S.A  Chymotrypsin  A4  and  trypsin were from  Boehringer  Mannheim 
Riochcmicals.  Indianapolis.  IN, U S  A,. Diazald  and  rrifluoroacetamido  succinic anhydride 
were purchased from Aldrich  Chemical  Company, Inc.. Milwaukee, WI. U.S.A., and 
oxo-L-norvaline  and  its radioactwe  [S-14C1 analogue wcre synthesized as described 
114C1 diarald was from Amerrham  Corporation, Arlington Heights. II, U S  A,. S-Diazo~4- 
(13) -  All other reagents were of analytserl  grade  and commonly available.  Methanolic 
HCI was prepared  by  the  dropwise  addition of 140 p1 of acetylchloride  into I ml of 
methanol.  The mr.ture was allowed 10 stand at room temperature for 5 min prmr to 
use. Aspartyl-N-acetylglucosamine methyl ester was prepared by methanolysis in 0.5 M 
aspartyl-N-acetylglucosamine by N-acetylation  with  acetic  a id  anhydride (14). PTC- 
NCI-methanal. for I h at 65 OC. N-acctylasparlylglucosamlne was prepared  lrom 
GlcNAc-Asn was prepared by incubatmg  GlcNAc-Asn at 20 OC for 30  minutes in 
from reagents by reverse-phase  HPLC ( IS) .  A complete FPLC unit. DEAE-Sephadex  A- 
clhsoolic  solution of 20 % TEA (”/“) and IO % (”/*) PITC.  The  derivative was purified 
SO. DEAE-Sepharosc CI-68. Concanavalin  A-Sepharose.  Sephacryl S-200 HR.  Mono Q HR 
and 10-15 W ,  and pH  gradicnr  3.9).  and  calibration  kits lor electrophoresis  and pel 
S/S column, Alkyl-Superose 515 column. polyacrylamide  PhartGelsTM(gradient 8.25 % 
protem  assay  and  callbration  of  isoelectric  focusing were purchased  from BioRad 
f i l t r a lm were from Pharmacia LKB Biotechnology Inc.. Uppsala,  Sweden.  Kits  for 
Laboratories.  Richmond,  CA, U.S.A , BioBrene  PlusTM.  TFA-treated  glass-fiber  filters  and 
all sequencing rcagcnrs were purchased  from  Applied Biosystems. be . ,  Foster  Ctty. CA. 
U.S A..  HPTLC~plates were from Merck Co. Darmstadt.  F.R.G.  High-performance  lquid 
chromatography was carried out with a Perkin  Elmer  Series  4-chromalograph equrpped 
compurlng integrator  (Perkin  Elmer  corporalron. Norwalk. CT. U.S.A.) or using l14M 
with a variable-wavelength  UV-VIS  detector, an ISS-I00 autosampler and a LCI-100 
Integrator from  Beckman Instruments. Inc.. Berkeley,  CA.  U.S.A..  Spherisorb S3 ODS2 
Solvent Delivery  Modules.  421A  Controller.  165  Variable  Wavelength Detector and 427 
column (IS0 x 4.6 mm. 1.d.) was from  Phase  Separadonr  Ltd.,  Deeside.  UK.  Rerchrom 3U 
300 A butyl column (50 x 4.6 mm, i.d.) from R e g s  Chemical  Company,  Morton Grove, 
U S.A , a Vydac 214TPS2 narrow bom column from The Separations Group, Herpena. CA. 
U.S.A.  and RP  aquapore C8. 300A column ( 2 . l m m  x 30 mm. 1.d.) f r m n  Appllcd 
Biorystems,  Foster  City.  CA,  U.S.A..  &counting was performed  with a LS 6800~counter 
from Beckman Instruments. Irvine, CA. U.S.A.. 
Enzyme A- 
using N 4 ~ ( g - N ~ a c s t y l g l u c o s a m i n y l j ~ L - ~ ~ p ~ ~ ~ g i ~ e  as substrate  measuring  the substrate 
Glycoasparaginase  array  durmg  the enzyme purlfleation was carrled out 
amount consumed  and  the aspartate amount liberated  by  high-performance  liquid 
chromatography (15). The reaction was carried out in 50 mM phosphate  buffer.  pH 7 5 .  
and 600 mM substrate  concentration.  The same method (IS) was used.  when action of 
caused loss of 1 pmol of substrate per minute  under  standard condiuonr.  The a c t m  of 
glyCOsSpdraginaSe on PTC-arparlylglucoramine war studied. One unit  (U) of the cnzymc 
derivatives was studied by thin-layer  chromillagraphy urmg n-butanol:acetnc scid:Il20 
glycoasparaginase on a-N.acelylated or a-carboxymethyla ted   aspsr ty lg lucosan>,ne  
(2:l:l by valj solvent system  and  the plates were stained  with  ninhydrin  and  orcinol. 
The  kinetlc  studies were carried out by a spectrophotometric  assay (II j using  IL 
Mullistat 111 centrifugal analyzer (Instrumentation  Laboramry.  Lexington,  MA, U.S.A.). 
Details of the  incubation  candstions  and reagent Concentraf~onS are found i n  the  legend, 
of Fig. 1. The  half-time of inactivation, T, was determined  from  the h e a r  plots of 
InWEo) versus time. where E i s  the  residual  enzyme mi*ity at time t in the presence 
of  inhihzlor  and Eo is  the  initial enzyme actwily at ljmc 1=0. The  half-time for 
inactivauon  and  the  observed Rrst.arder rate Constant far inhibllion.  Kobr, are relrwd 
(16): 
Kobr= 
In2 
T 
The  protection of glycoasparaginase by its  substrate,  aspartylglycasamine (Ll, sgrittst 
the inactivation caused  by  DONV ( I )  was studied in various  concentrations of the 
compounds in SO mM  phosphate  buffor,  pH  7.5.  and  the  inhibirion conslant (KL) was 
derived  from (16. 17): 
1 KI(I+ILI/KL)+III 
Kobs k311I 
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DONV Inactivation of Glycoasparaginase 
Gils-Lmund Cko- 
methsnolic  hydrochloric  acid.  80OC,  16  h, with  mannitol  and  mya-inositol as internal 
After  methanalysis  of  glyeoarpnraginare in 0.5 M 
standards. the quantitative  monosaccharide  analysis  was  performed by capillary gar- 
liquid  chromatography  using a Perkin  Elmer  gas  chromatograph  model  8500  equipped 
with a flame  ionization  detector  (Perkin  Elmer  corporation.  Norwalk.  CT. U.S.A.). The 
trimcthylsilylated  monosaccharide  rivatives were separated on P 25-m  capillary 
column (25 m x 0.2 mm, i.d.)  coated  with SE-30 (Nordion Ltd. Helsinki,  Finland)  (18). 
. .  
. .  The  purified  protein  was  hydrolyzed in 6  M HCI at 110 OC for 16 
hours  and  the  liberated  amino  acids were analyzed as their  a-phtalaldehyde  derivatives 
with an automatic  LKB  4151  Alpha  Plus  amino  acid  analyzer  (LKB-Products  AB, 
Bromma, Sweden)  using  norleucine as an  i ternal  standard.  Proline was measured by 
HPLC  using  precolumn  PTC  derivatization. 
e c d -  
with  the  PhastSystemTM  according to the  manufacturer's  instructions  using  prc-cast 8. 
The  native  PAGE  electrophoresis was performed 
25 46 gradient gels (PhartSystemTM  Separation  Technique  file No.  120).  Protein  bands 
and  molecular  weight  standards  were  localized by silver  staining.  SDS-PAGE war 
carried out with 12 % gels and  protein  markers  with  known  molecular  weight.  The 
samples were denatured  for 10 mm at 90 OC in 2.5 96 SDS  and  5 46 mercaptoethanol, and 
loaded on SDS polyacrylamide gel according IO Laemmli  (19).  After  migratmn at 30 
mA. the gels were stained  with  silver.  Isoelectric  focusing was performed  with  t e 
proteins were localized  with silver  staining. 
PhastSystemTM  according to the  manufacturer's  instructions  (pH  gradient  3-9)  and  the 
QttLcr analvtlcal WLhQd5 Protein  assays were performed  with  t e  Bio-Rad  protcin 
assay  kit  according to the  manufacturer's  instructions.  The  purified  glycoasparaginase 
preparation was tested  for  the  activity  of U-N-acetylglucoraminidare, a-mannosidase, 0 -  
corresponding  4-methylumbelliferone  derivatives as substrates  (20).  The pH  optimum 
fucoaidase,   a-iduronidase.   &galactosidase  nd  a-N-acetylneuraminidase  using 
Of glycoasparaginase  was  determined over a pH  range  of  3.0 to 9.5 in  intervals of 0.5  pH 
Units. The  following  buffers  were  used:  Brittan-Robinson's  universal  buffer (50 mM. 
5.5-8.0).  The  ffect of the ion strength was evaluated  with  Tris-HCI  and  phosphate 
pH 3.0-9.5) (21). Tris-HCI (50 mM. pH 5.5 . 9.0) and potassium-phosphate  (50  mM, pH 
stability,  aliquots of the  purified  enzyme  preparation were incubated in the  prcsence of 
buffers in concentrations  from 10.0 mM to I M  (pH  7.5).  For  determination of thermal 
0.1 % bovine serum albumin at 4-100 O C  for 60 min followed by immediate  immersion 
i n  an Ice bath. 
. .  . The isolation of leukocytes war 
carried out at room  temperature,  Other  purification  steps were carried out at  4 OC in 
0.1 mM DTT  and 0.5 mM EDTA  except  Concanavalin  A-chromatography  that was 
buffers (or water)  containing  0.002 % Hibitane. 0.1 mM PMSF. 100 KIUiI  of  aprotinin. 
performed in the  absence of EDTA. In each  step. thefractions  Containing 
glyeoasparaginare  activity wcre pooled  and  utilized  for  the next step.  The  buffy c o ~ t  
was allowed to sediment  with an equal volume of  dextran (6 %) and  saline  for  2-3 
hours. The upper  layer  containing  Icukocytes  was  centrifuged ( I O  minutes at 500 x g). 
The  contaminating  erythrocytes  were  moved by hemolyzing in water and  the 
lcvkocyte  mixture were stored at -20 OC. 1  liter  of  packed  leukocytes was frozen  and 
thawed  three  times. I liter  of 50 mM phosphate  buffer.  pH 6.3, was added  and  the 
suspension was centrifuged  for  30 minutes at 20 000 x g and  thc  pellet was discarded. 
The  proteins in the  solution were precipitated  with 0.5 % caprylic  acid ( v k )  and  the 
supernatant  was  dialyzed  for  24  hours  against 20  mM imidazole-HCI buffer,  pH 6.8. The 
protein mixture was applied to a 70-ml DEAE-Scphadex A-50 column in a glass 
sintered  funnel  and  the  unbound  protein  was  eluted  from  the gel by  washing  with 20 
mM imidazole-HCI,  pH  6.8.  The  glycoasparaginase.  which was bound lo the gel, was 
rcleascd  by 0.5 M  NaCl  and  ialyzed with the starting buffer  using an Amicon YM-30 
filter  and  sample  concentrator.  The  nzyme  concentrate was then  applied to a column 
of DEAE-Sepharose  CI-6B  (2.6 x 27  cm) and  eluted with a linear  NaCl  gradient  (0-0.3 M 
NaCI). The fractions containing  the  enzyme  activity  were  pooled  and  ialyzed with 
EDTA-free starting buffer containing I mM Mg++, MnCC, Ca++ and 0.5 M NaCl  (buffer 1. 
Fig. 6 8 )  Tho  enzyme  preparation  was  further  purified an a 9-mI Concanavalin A-  
Sepharore column. The  nzyme  interacted with  the  lectin  and wa5 eluted out of  the 
column  with a buffer  containing 1.0 M  a-methyl-glucoside  and 1.0 M  NaCl  (buffer  2,  Fig. 
68) .  Gel filtration of the  concentrated  nzyme  preparation was performed On a 
Sephacryl  S200 HR column (1.6 x 50  cm i.d.). The  column  was  equilibrated with 50 mM 
phosphate  buffer. pH 7.0, containing 0.5 M  NaCl  and  eluted with a flow rate of 0.3 ml 
per minute.  The  fractions  containing  the  lycoasparaginasc  a tivity were pooled. 
dlalyzed  and  concentrated to 2 ml of 50 m M  potassium  phosphate  buffer, pH  7.0. 
containmg 2.0 M ammonium  sulphate.  The  sample was chromatographed on a HR 5/5 
Alkyl  Superose  column (0.5 x 5.0 cm i.d.)  that was eluted  with a linear  gradient of 
ammonium  sulphate  (2.0 - 0 M), 30 ml total. The  fractions  containing  the  nzyme 
activity  were  pooled  and  ialyzed  against  20  mM  Bis-Tris-HCI.  pH  6.2.  containing 5 5t 
5.0 cm i d )  and  eluted  with a 0-0.3 M gradient of NaCI. The cnzymatically active 
betaine. The pooled  enzyme  was chromatographed on a Mona Q HR5i5 column (0.5 x 
fractions were collected  and  dialyzcd  against  50 mM phosphate  buffer.  pH 7.5. 
containing  30 96 of  glycerol ( v i " )  and  stored  at  -20 OC. The  subunits of 
glycoasparaginase were separated by reverse-phase  HPLC on a Rexchrom  butyl column 
(4.6 x 50 mm. i.d.)  using  the 0.1 % TFAiacetonitrile  solvent  system. 
w l i o e  of -e with  DON 
glycoarparaginare was labeled  with 10 m m d  of DONV in 50  mM phosphate  buffer.  pH 
V  and [ 5 - 1 4 C l W  10 "mol of the 
7.0.  for  24 h at room temperature.  For  radioactive  labeling.  14 nmol of  the 
glycoasparaginase was incubated  for  24 h at room temperature  with  1.12 pmol of I S -  
unlabeled  OONV war added and  the  sample was incubated for  anothcr 2  h at room 
I4C1  DONV  (11.2  pCi) in 50 mM  phosphate buffer,  pH 7.0. After 24 h. 14 pmol of 
temperature. Thc L-  and  H-chains  of  the  nzyme were separated by HPLC  and  etails 
of  the  chromatography are given in the  legend  of  Fig.  3.  Aliquots  of  each  fraction were 
subjected to fl-counting.  The  fractions were evaporated 10 dryness  and  stored at -70 OC. 
Covalent incorporation of [5-14C]-DONV  into  the  nzyme was assessed  aftcr  separation 
of the  subunits by HPLC. The stability of the  label in the  HPLC  conditions was evaluated 
radioactivity  and  the amount of protcin in each  HPLC  fraction was used in calculation of 
by rechromatography  of  labeled,  HPLC  fractionated  polypeptides. Mcxsvrcment of  the 
covalent binding  stochiomctry. 
was  digested  with  chymotrypsin  (2.7 pg) in 2  M urea. 0.1 M  ammonium  bicarbonate.  pH 
The  [5-14Cl-DONV  labeled  L-chain  (7 nmol. 135 pg) 
7.0 at 37 OC for  4 h and  the  peptides  wcrc  separated by HPLC.  Trypsin  digestions were 
performed  under  similar  conditions  for  6h.  For  cyanagcn  bromide  cleavage,  3nmol of 
(750 m o l )  in 70 % formic  acid  for  24  h at 25 OC. Five volumes of 0.1 5% "FA in water 
[5-14C1-DONV  labeled  and  HPLC  purified  L-chain was incubated  with  cyanogen  bromide 
was added  and  thc  sample was injected onto the  HPLC  column. The radioactive  peptides 
generated by the cleavages were  purified  by  HPLC on a Vydac  218TP52  nanow  bore 
column. Aliquats from each  HPLC  fraction  were  subjected to the  B-counting  and  those 
containing  the  radioactivity were evaporated to dryness  with  a  Szvant  SpeedVacT 
and  used  for peptide  s quencing.  Details  of  the  chromatography  arc  given in the 
legends  of  Fig.  3and  4. The separation  of  tryptic  peptides was performed  by  reverse- 
phase  HPLC.  Effluent was monitored at 225 nm with an Applied  Biosystcms  783A UV- 
detector. A 0% to 70%  linear  gradient  of  acetonitrile in 0.1% aqueous  trifluoroacctic  acid 
at  200  mlimin over 50 min was used to eluate the  peptidcr  from  the  HPLC  column. 
. . . .  
Applied  Biosystems  477A  protein  sequencer  equipped  with  on-line l2OA PTH  analyzer. 
Automated  Edman  degradations  were  pcrformed  with an 
BiohreneTM WPS applied to the glass filter  and  washed  prior to sample  application. All 
the  sequencer  eagents were from  Applied  Biosystems  (Applied  Biosystems,  Fostcr  City. 
CA. U.S.A.). 
synthetic  techniques on an  Applied  Biosystems  Model  430A  peptide  rynthetircr 
The  synthetic  peptide  was  prepared using  automated  solid  phase 
modified to perform  0.1 mmolc scale reactions  and  flow  through  chemistries.  The 
peptide was HPLC  purified  and  its sequence was confirmed  by  automated  Edman 
analysis  and mass spectrometry. 
n of  Peptidcs were converted to their  corresponding 
peptide  (22).  After  standing  for 1 hr a t  room temperature.  the solvent was removed 
methyl  esters by the  addition  of 100 pl of  freshly  prepared  mcthanolic  HCI to the  dried 
under  vacuum in a Savant  SpecdVacTM. 
MAT,  San lose. CA)  triple  quadrupole mass  spectromctcr  equipped  with  a  40  keV 
Mass  spectra were recorded on a  Finnigan MAT  TSQ70 (Finnigan 
cesium  ion  gun  and a 20  keV  conversion  dynode as previously  described  (23).  Mass 
analysis was pcrformcd by adding  1 VI of a 5%  acetic acid  solution  containing  the 
peptide  mixture  of  peptides  at  10-50  pmol level to I p1 of  monothiglycerol on a gold 
matrix  intn  the gar phasc by bombardment  with 8-10 keV  Cs+  ions  generated  with  the 
plated.  copper  probe  tip, I mm in diameter.  Peptides were sputtered out of  the  liquid 
cmium ion gun. Typically  the mass range of m/z 400-3000 was scanned 10 times at 
390  daltonris  and the  resulting m a w  spectra were summed  together.  Scqucncc 
rclccted  through a 3-6  dalton mass  window in quadrupole 1. Argon prcsrurc in the 
analysis of peptides was performed  as  previously  described  (22, 23). Parent  ions were 
collision cell was 3x10-5 torr and  collision  energies  wried between 30 and 40 cV. 
Typically. 10-15 scans were summed  together. 
Results 
The  caprylic  acid  precipitation  and  hatch  technique an DEAE-Scphader A-SO cnabled us 
-ion of Glv- The purification  scheme  is ummarized in Table  IV. 
to remove a significant  amount of inactive  material  without loss of  enzyme  activity.  The 
(Fig.  6A).  The  ability of the  nzymc to interact  with  Concanavalin  A-lectin  was  utilized 
glycoasparaginase  activity  eluted at 80 mM NaCl  from  DEAE-Sepharosc  CI-6B  column 
a-methyl-glucoside  and 1.0 M  NaCl  (buffer 2. Fig. 68).  The  Sephacryl  S-200 HR gel 
next in the  purification.  The  nzyme was bound to the column and  eluted with 1.0 M 
protein  solution  completely  free from pigments. In  hydrophobic  interaction 
filtration  (Fig,  6C)  eliminated  the low and  high m ~ l e c ~ l a r  weight  proteins  and  yielded a 
chromatography on Alkyl  Superose.  the  nzyme  activity  eluted at 0.5 M  ammonium 
sulphate in thc  major  protein  fraction  (Fig.  6D). In the final s a p  of  anion  exchange 
chromatography on a Mono Q column  (Fig.  6E).  the  enzyme  eluted at 0.15 - 0.20 M salt 
concentration as a wide group of peaks  indicating  considerable  charge  heterogeniety. 
showed  a single.  symmetric  protein  peak.  that was enzymatically  active  (data not 
Rechromatography  of such a preparation on Scphacryl  S-200 HR and  Alkyl  Superore 
shown).  This  enzyme  preparation was complctcly  inactive in respect to a - N -  
galactosidase  activity.  Thc  enzyme was stored  in 30% glycerol (v i " )  at -20 OC without 
acetylneuraminidase. B-N-acetylglucasaminidare, a-mannosidarc.  a-iduronidasc and 8 -  
1055 of  activity over sevcral months. 
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Fig. 6. 
Chromatographies were carried  out as described under "Experimental Procedures". In 
each step. all fractions  containing glycoasparaginase a c t i v i t y ( m Z 7 Z )  were poolcd and 
utiltzed  for the next step. 
A. Elution profile of the DEAE Sepharose CI-6 B column. The column was eluted at a flow 
rate of 0.7 mllmin and fractions of 10 ml were collected. 
B. Elution profile of the ConA4epharosc column. The flow rate for the column was 0.5 
mllmin and the fraction size was 5 ml (buffer 2 IM o-mcthylglucoside and I M NaCI). 
C. Elution  profile o f  the Sephacryl S.200 HR column. Elution was performed at a flow 
rate of 0.3 mllmin and fractions of 2.2 ml were collected. 
rate of 0.5 mllmin and fractions of 1.0 ml were collected. 
D. Elution  profile of the Alkyl  Superorc column. The elution was performed at a  flow 
E. Elution profile o f  the MonoQ 515 column. This column was eluted at a flow rate or 1.0 
mllmin and 0 .3  ml fractions were collected. The gradient ( ) and UV-absorbance at 
280 nm (-----). (AGA=plycoasparrginns~). 
The yield from I L of packed leukocytes was 340 Lg of pure and active enzyme with a 
rpeif ic act ivi ty of 2.2 Ulmg. The yield of purification was I2 % and the speclfie activity 
increased 4600-fold as comDared with that of the crude extract (Table IV). 
TADLE IV  
PURIFICATION OF GLYCOASPARAGINASE FROM I L O F  HUMAN LEUKOCYTES. 
Total units Total protcin  Yield 
mU  ms  mU1mg 
Spci f lc  activity 
Homogenate 6400 12 800 1 0 0  0.5 
Caprylic acid 9460 
DEAEl 6330 
4 3 0 0  
I 3 7 6  
>IO0 2.2 
DEAE I I  6624 2 8 8  
>IO0 4.6 
Con A 5060 
> I 0 0  23.0 
I 8  
3 .2  
79 
30 
28 I 
Alkyl S 1105 0.88 17 
587 
MonoQ 751 
I255 
0.34  I2 2210 
woo HR l m n  
Fold 
" 
I 
4.5 
4 6  
9.5 
5 8 5  
2615  
1015 
4600 
Mdeculsr w i e h t  and n-
single  protein hand wtth an rpparent Mr of 8 3 . W  (Fig. 7A). By gel fIltralion on I 
On native PAGE. glycoasparaginase ran 1 s  a 
Scphacryl S-200 FIR column  calibrated  with  marker proteins. the Mr was estimated as 
76.000 (data not shown) When the enzymc prepantian was incubated i n  2.5 '% SDS 
and > % mereaptoethmol far IU minutes at 90 OC.  the protein  completely dissociated to 
give two protein bands w t h  the rclntiw molecular weight of 25.000 and IY.000 i n  I ?  
% SDSPAGI.: (Fig. 7B). In a pH gradient. the native enzyme dirtrlhutcd betwecn pH 4.6. 
5.2 on iroclcctrx focusing (Fic. 7C) and conmined at least five separate  bands indicating 
charge heterogeneity. 
C 
(-) pH 
Fig. 7. MQJsdar weinht. -FomnoritinId o f  ~ ~ u u h d h u m a  . .  
lcIkxYEPlvFoaroaraPtnars. 
. .  
A.  Polyacrylamide gel cleclrophoreris of the purified enzyme (lane I) and the 
molecular weight markers (lane 2) .  Electrophoresis was carried out on a 8.2s Lk 
gradient gel. which was stained with silver. 
B. SDS-polyacrylamide gel electrophoresis of the purified enzyme (lane I )  and the 
carried out on I 12 % gel. which was stained with silver. 
molecular weight markers (lane 2) under reducing  conditions.  Electrophoresis was 
C. lswlectric  focusing or the purified enzyme (lane I) and the marker proteins (lane 2). 
IEF was performed on I pH 4.5.9.0 gradient gcl. which was stained with silver. 
Glycoarparaginare  activity was  lost rimultrncovsly  with the disappearance of the native 
enzyme durmg the incubation before SDS-PAGE  electrophorcsir (Fig. 8). The intensity 
o f  the ncw bands at 19.000 and 25.000 increased rapidly  with the progression o f  
dissociation. At thc same time. protcin bands with glycoasparaginase activity were 
consistently observed at 67.000 and 55.000 regions  untll the native enzyme band had 
completcly  disappeared.  The  proteins 11 19.000 and 25.000 were enzymatically 
inactive  (Fig. 8). On thcsc basts we conclude that glycovrparaginare o f  human 
leukocytes is  a polymeric and most obviously a heterotetramcric protein  of L2H2- typc  
with an apparent M r  of about 88,000 and i t  is  composed of  light and heavy subunits 
with M r  o f  19.000  and 25.000. 
The linkages between the subunits were ruptured i n  0.1 % TFA and the liberrted 
subunits were isolated  by reverse-phase HPLC  (Fig. 9) .  The isolated.  enzymntically 
inactive fractions. wcce subjcctcd to SDS-PAGE.  which  indicated that the flrst mqar 
p e a k  eluting wnth retention  time of 9.3 minutes represcnted the L-subunit (MI l9,OlNl) 
and the second major perk  with retention  time o f  13.8 minulcI reprcrented the If .  
subunit (Mr 25.000). respectively. 
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TARLE V 
AMINO ACID COMPOSITION O F  LEUKOCYTE  GLYCOASPARAGINASE (MOL%) 
APD COMPARISOS T O  ASPARATYI,(;I.UCOSAhllSIDASES PRESESTED I N  
I.ITERATURE 
7.8 
10.9 
6.X 
1 I . R  
I .8 
I I .(I 
5.4 
0.4 
6.4 
3 . 4  
4 . 4  
2.1 
2.6 
4 . 3  
4 .3  
n.m. 
10.6 
5.0 
5.X 
7 3  
15.4 
4.0 
5.7 
s.9 
I .9 
0.4 
R.8 
3.9 
3.4 
5.3 
2.3 
2.3 
4 8  
5.4 
3.7 
11.0 6.S 
7.8 
6.3 
7.11 
I I.X 
6.R 
n.m. 
3.3 
3.8 
6.3 
3.3 
3.8 
1.8 
4.5 
6.3 
1.2 
10.6 
4.0 
. .  
m d e  comno- 
approximalely IS Ck of !he weight of the cnryme i s  carbohydrate and thc 
The  monosaccharide  analysis  indicated thz t  
monosaccharidc composition i s  shown in Table VI. The high molar r m o  of mannose 
indmtes t h a 1  the prolem mos1 l ikely contains  both  complex-typc and high mannose- 
type N.glycoridic  arhahydrate cham.  
T A n L E  \'I 
SUGAR CO\1POSITIOS OF HU.MAN LEUKOCYTE GLYCOASPARAGINASE 
Component sugar nmollmg protein molar ratio 
" ~ 
L.F"COSC 39 
D.Mannore 
D.G;llactorc 
D.Gl"corc 79 
S.Acctyl-D-galacto~amine 14 
S-Acelyl-D-glucoslmine 
S-Acclylncuraminic actd 
I 6 4  
I 2 2  
2 8 2  
I 1 9  
0.4 
0s  
1.3 
0. I 
1.7 
1.3 
3.0 
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Fig. IO. The effect of oH.  on hu- . .  
A. Dependence of glycoanparaginase  activity on hydrogen  ion concentration was 
measured in 50 mM Britton-Robinsson's  universal  buffer ( ), 50 mM Tris-HCI 
buffer ( ) and 50 mM ptassiurn phosphate buffer ( -p- ). Each data  point 
rcprcscntr  the  mean of two  separate  assays. 
B .  Effect of ionic  strength on the  enzyme activity ( Tris-HCI. + patasslum 
phosphate).  Each  data  paint  represents  the mean of  two  assays. 
C. Effect  of  temperature on the  nzyme  activity Each data  point  rcprcscntr  the mean of 
two separate  assays.  The  purified  enzyme was incubated  in  Trir-HCI  buffer. pH 7.5. in 
the presence of 0.1% bovine serum albumin at 4 - l0WC for 60 mi".. 
20 - 
- c 
E . 
3 10-  
> 0 
 - 50 -10 0 10 1/151 20 30 40 5C 
0 IO0 
ts1 tun) 
200 
Fig. I I .  The effect of su- on  human 
A double-reciprocal  plot of the  same  data  isshown  i   the  inset.  Each  data point 
represents  the mean of  two  separate  assays. 
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